scispace - formally typeset
Search or ask a question
Institution

Hospital for Special Surgery

HealthcareNew York, New York, United States
About: Hospital for Special Surgery is a healthcare organization based out in New York, New York, United States. It is known for research contribution in the topics: Arthroplasty & Population. The organization has 5440 authors who have published 12013 publications receiving 472144 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The estimated relative risk of death from an increase of one in the comorbidity score proved approximately equal to that from an additional decade of age.

5,388 citations

Journal ArticleDOI
TL;DR: A new total knee rating system has been developed by The Knee Society to provide an up-to-date more stringent evaluation form and eliminates the problem of declining knee scores associated with patient infirmity.
Abstract: A new total knee rating system has been developed by The Knee Society to provide an up-to-date more stringent evaluation form. The system is subdivided into a knee score that rates only the knee joint itself and a functional score that rates the patient's ability to walk and climb stairs. The dual rating system eliminates the problem of declining knee scores associated with patient infirmity.

4,505 citations

Journal ArticleDOI
17 Jul 2014-Immunity
TL;DR: A set of standards encompassing three principles-the source of macrophages, definition of the activators, and a consensus collection of markers to describe macrophage activation are described with the goal of unifying experimental standards for diverse experimental scenarios.

4,287 citations

Journal ArticleDOI
TL;DR: In this paper, the authors summarize the signalling and epigenetic mechanisms that regulate type I IFN-induced STAT activation and ISG transcription and translation and conclude that these regulatory mechanisms determine the biological outcomes of type I ILN responses and whether pathogens are cleared effectively or chronic infection or autoimmune disease ensues.
Abstract: Type I interferons (IFNs) activate intracellular antimicrobial programmes and influence the development of innate and adaptive immune responses. Canonical type I IFN signalling activates the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, leading to transcription of IFN-stimulated genes (ISGs). Host, pathogen and environmental factors regulate the responses of cells to this signalling pathway and thus calibrate host defences while limiting tissue damage and preventing autoimmunity. Here, we summarize the signalling and epigenetic mechanisms that regulate type I IFN-induced STAT activation and ISG transcription and translation. These regulatory mechanisms determine the biological outcomes of type I IFN responses and whether pathogens are cleared effectively or chronic infection or autoimmune disease ensues.

2,273 citations


Authors

Showing all 5601 results

NameH-indexPapersCitations
Stephen J. O'Brien153106293025
Lloyd J. Old152775101377
Richard B. Devereux144962116403
Thomas J. Walsh13199184597
Henrik Kehlet130106976338
Russell F. Warren12864750685
Scott L. Friedman12648862931
Csaba Szabó12395861791
Charles S. Lieber12064750420
Kenneth H. Mayer115135164698
Jeffrey N. Katz11469556439
Michael B. Brenner11139344771
Barbara B. Kahn10328153325
Mary J. Roman10036548687
Thomas A. Einhorn9433032850
Network Information
Related Institutions (5)
Rush University Medical Center
29K papers, 1.3M citations

92% related

Mayo Clinic
169.5K papers, 8.1M citations

87% related

Thomas Jefferson University
38.2K papers, 1.7M citations

86% related

Cleveland Clinic
79.3K papers, 3.4M citations

86% related

NewYork–Presbyterian Hospital
25.3K papers, 1M citations

86% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202344
2022137
20211,116
20201,018
2019868
2018791